ROBUSTI, GIULIA
ROBUSTI, GIULIA
Dipartimento di Oncologia ed Emato-Oncologia
Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma
2026 R. Noberini, I. Bischinioti, S. Zanetti, A. Vai, G. Sedda, E. Mane, C. Bardoni, G. Robusti, M. D'Ercole, R. Mancari, U. Cavallaro, N. Colombo, L. Bertolaccini, M. Lombardi, N. Fusco, L. Spaggiari, D. Galetta, T. Bonaldi
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes
2025 R. Noberini, G. Robusti, A. Vai, E.O. Savoia, M.G. Jodice, G. Bertalot, B. Cat, I. Pallavicini, G. Bonizzi, M. Capra, C.A. Sangalli, F. Zambelli, N. Fusco, S. Pece, G. Pavesi, S. Minucci, T. Bonaldi
A MULTI-OMICS APPROACH TO DISSECT ABERRANT EPIGENETIC MECHANISMS IN TRIPLE NEGATIVE BREAST CANCER
2023 G. Robusti
A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression
2023 E. Di Nisio, V. Licursi, C. Mannironi, V. Buglioni, A. Paiardini, G. Robusti, R. Noberini, T. Bonaldi, R. Negri
Mass spectrometry-based characterization of histones in clinical samples: applications, progresses, and challenges
2022 R. Noberini, G. Robusti, T. Bonaldi